Cargando…
Dantrolene is neuroprotective in Huntington's disease transgenic mouse model
BACKGROUND: Huntington's disease (HD) is a progressive neurodegenerative disorder caused by a polyglutamine expansion in the Huntingtin protein which results in the selective degeneration of striatal medium spiny neurons (MSNs). Our group has previously demonstrated that calcium (Ca(2+)) signal...
Autores principales: | Chen, Xi, Wu, Jun, Lvovskaya, Svetlana, Herndon, Emily, Supnet, Charlene, Bezprozvanny, Ilya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235068/ https://www.ncbi.nlm.nih.gov/pubmed/22118545 http://dx.doi.org/10.1186/1750-1326-6-81 |
Ejemplares similares
-
Ataxic Symptoms in Huntington’s Disease Transgenic Mouse Model Are Alleviated by Chlorzoxazone
por: Egorova, Polina A., et al.
Publicado: (2020) -
Tetrabenazine is neuroprotective in Huntington's disease mice
por: Wang, Hongyu, et al.
Publicado: (2010) -
The role of ryanodine receptor type 3 in a mouse model of Alzheimer disease
por: Liu, Jie, et al.
Publicado: (2014) -
Evaluation of Dimebon in cellular model of Huntington's disease
por: Wu, Jun, et al.
Publicado: (2008) -
Therapeutic Effect of Berberine on Huntington’s Disease Transgenic Mouse Model
por: Jiang, Wenxiao, et al.
Publicado: (2015)